Based on TCM theory, weakness of the spleen and stomach is the main cause of IBS-D, and spleen deficiency and dampness excess syndrome is a common type in clinical practice[16,17]. The therapeutic effect of moxibustion is mainly derived from the thermal effect of moxa burning on acupoints of body surface[18] and the chemical stimulation of drug components in moxa leaves[19,20], which can achieve the effect of invigorating spleen and dispelling dampness. Mild moxibustion is a complementary altern
Conditions
Interventions
Patients were placed in supine position, and moxa strips were placed on the moxibustion racks with the burning end of the moxa strips perpendicular to the acupoints and 3 to 5cm from the acupoints, to
Experimental Other
moxa strips
Sponsors
Lijiang Ji
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1.Patients should meet both TCM and Western diagnostic criteria of IBS-D; 2.Patients at age of 18 to 65 years old; 3.No history of relevant treatment before enrollment or with discontinuation of treatment with Chinese medicine, antidiarrheal drugs and antispasmodics for more than 1 month; 4.The total score of the IBS Severity Scoring System score(IBS-SSS) is more than 75; 5.Voluntary participation in this study and signing of the informed consent form.
Exclusion criteria
Exclusion criteria: 1.Patients with IBS-C, IBS-M, and IBS-U; 2.Patients with inflammatory bowel disease, organic intestinal lesions, peptic ulcer, infectious diarrhea; 3.Patients combined with severe cardiovascular, hepatic, renal, endocrine and hematopoietic system diseases; patients with other diseases other than diarrhea that may affect the test results that cannot be discontinued; patients with mental illness; 4.Patients who are pregnant or lactating, and those who have a birth plan from their enrollment to 1 month after the end of the trial; 5.Those who have participated in other clinical trials within 1 month.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IBS-SSS 8 weeks includes five aspects with a score range of 0 to 100 out of 500 for each indicator | — |
Secondary
| Measure | Time frame |
|---|---|
| Irritable Bowel Syndrome-Quality of Life(IBS-QOL)score 8 weeks The score of Irritable Bowel Syndrome-Quality of Life | — |
Countries
China
Contacts
Public ContactYunyi Chen
Changshu Hospital Affiliated to Nanjing University of Chinese Medicine
Outcome results
None listed